Yingliang Wu Selected Research

Scorpion Venoms (Scorpion Venom)

12/2018	The Scorpion Venom Peptide Smp76 Inhibits Viral Infection by Regulating Type-I Interferon Response.
1/2018	Expression of recombinant α-toxin BmKM9 from scorpion Buthus martensii Karsch and its functional characterization on sodium channels.
1/2017	Feeding recombinant E. coli with GST-mBmKTX fusion protein increases the fecundity and lifespan of Caenorhabditis elegans.
4/2016	The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases.
2/2016	Identification of two novel Chlorotoxin derivatives CA4 and CTX-23 with chemotherapeutic and anti-angiogenic potential.
4/2014	Sj7170, a unique dual-function peptide with a specific α-chymotrypsin inhibitory activity and a potent tumor-activating effect from scorpion venom.
4/2013	Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.
1/2013	hERG potassium channel blockage by scorpion toxin BmKKx2 enhances erythroid differentiation of human leukemia cells K562.
7/2011	Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.
1/2011	Differential molecular information of maurotoxin peptide recognizing IK(Ca) and Kv1.2 channels explored by computational simulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yingliang Wu Research Topics

Disease

30	Neoplasms (Cancer) 07/2022 - 05/2010
14	Infections 01/2021 - 01/2011
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022 - 06/2017
7	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 02/2011
6	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2016
6	Virus Diseases (Viral Diseases) 01/2022 - 09/2015
5	COVID-19 03/2022 - 01/2020
5	Inflammation (Inflammations) 10/2021 - 11/2014
4	Lung Neoplasms (Lung Cancer) 01/2022 - 10/2019
4	Neoplasm Metastasis (Metastasis) 09/2020 - 04/2014
3	Ataxia (Dyssynergia) 01/2021 - 10/2005
3	Channelopathies 01/2018 - 01/2011
3	Glioma (Gliomas) 02/2016 - 05/2010
3	Bacterial Infections (Bacterial Infection) 08/2012 - 11/2008
2	Lymphoma (Lymphomas) 01/2022 - 03/2018
2	Peritonitis 10/2021 - 01/2018
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 03/2021 - 11/2019
2	Epilepsy (Aura) 01/2021 - 01/2017
2	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2020 - 02/2015
2	Hypersensitivity (Allergy) 01/2019 - 03/2017
2	Adenocarcinoma 06/2017 - 01/2013
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2015 - 10/2013
2	Fibrosarcoma 02/2015 - 08/2012
2	Cardiotoxicity 01/2014 - 06/2011
2	Edema (Dropsy) 12/2013 - 12/2005
1	Post-Acute COVID-19 Syndrome 05/2022
1	Sepsis (Septicemia) 10/2021
1	Bites and Stings (Sting) 01/2021
1	Tick Bites 01/2021
1	Pruritus (Itching) 01/2021
1	Rheumatoid Arthritis 11/2020
1	Dermatomyositis (Dermatopolymyositis) 11/2020
1	Melanoma (Melanoma, Malignant) 11/2020
1	Severe Fever with Thrombocytopenia Syndrome 01/2020
1	Ulcer 08/2019
1	Wounds and Injuries (Trauma) 08/2019

Drug/Important Bio-Agent (IBA)

18	Peptides (Polypeptides)IBA 01/2021 - 02/2007
16	Pharmaceutical PreparationsIBA 01/2022 - 02/2011
10	Scorpion Venoms (Scorpion Venom)IBA 12/2018 - 01/2011
6	VaccinesIBA 01/2022 - 01/2019
5	Phenol (Carbolic Acid)FDA Link 01/2022 - 03/2016
5	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2011
5	Anaplastic Lymphoma KinaseIBA 03/2021 - 03/2018
5	DefensinsIBA 01/2021 - 12/2017
4	Phosphotransferases (Kinase)IBA 01/2022 - 03/2018
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2011
4	Ion Channels (Ion Channel)IBA 01/2021 - 01/2011
4	fosbretabulin (combretastatin A4)IBA 12/2015 - 08/2012
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022 - 03/2018
3	Tubulin ModulatorsIBA 01/2022 - 01/2017
3	Immune Checkpoint InhibitorsIBA 03/2021 - 08/2020
3	Potassium Channels (Potassium Channel)IBA 11/2020 - 02/2007
3	TubulinIBA 01/2020 - 02/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 11/2011
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2022 - 08/2018
2	2- methoxy- 5- ((3,4,5- trimethosyphenyl)seleninyl)phenolIBA 01/2022 - 03/2016
2	p38 Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2020
2	B7-H1 AntigenIBA 03/2021 - 11/2020
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2021 - 05/2008
2	CytokinesIBA 01/2021 - 08/2019
2	Indicators and Reagents (Reagents)IBA 11/2020 - 08/2019
2	VenomsIBA 01/2020 - 02/2014
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 01/2014
2	CrizotinibIBA 10/2019 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 08/2019 - 01/2019
2	Interleukin-2 (IL2)IBA 01/2019 - 02/2015
2	InterferonsIBA 12/2018 - 01/2016
2	PotassiumIBA 01/2017 - 01/2013
2	Chloride Channels (Chloride Channel)IBA 02/2016 - 05/2010
2	ChlorotoxinIBA 02/2016 - 11/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014 - 06/2011
2	4-methylcyclopentadecanoneIBA 01/2014 - 12/2013
2	Xylenes (Xylene)IBA 12/2013 - 12/2005
2	2- methoxy- 5- (2- (3,4,5- trimethoxyphenyl)thiophen- 3- yl)anilineIBA 01/2013 - 08/2012
1	Angiotensin Receptor AntagonistsIBA 03/2022
1	ceritinibIBA 01/2022
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2022
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2021
1	aluminum sulfate (alum)IBA 10/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Kv1.2 Potassium ChannelIBA 01/2021
1	CalciumIBA 01/2021
1	Salivary Proteins and PeptidesIBA 01/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021
1	capivasertibIBA 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 11/2020
1	Biomarkers (Surrogate Marker)IBA 11/2020
1	Programmed Cell Death 1 ReceptorIBA 11/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2020
1	PiperazineIBA 01/2020
1	Carrier Proteins (Binding Protein)IBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	SB 203580IBA 01/2020
1	Vitamin D FDA LinkGeneric 01/2020
1	Hemoglobins (Hemoglobin)IBA 08/2019

Therapy/Procedure

14	Therapeutics 05/2022 - 05/2010
3	Immunotherapy 03/2021 - 08/2020
2	Drug Therapy (Chemotherapy) 07/2022 - 08/2020
2	Intravenous Injections 03/2016 - 08/2012